Taken together, our results suggests that the effects of miR-451 on MDR1 expression appear to modulate anti-myeloma agents' effectiveness by inhibiting the expression of certain transcriptional factors involved in suppressing MDR1 gene activation. Here, ABCB1 is linked to plasma cell myeloma.